2026
article
OpenAlex
Andrew Kühn, Valentina Marulanda-Corzo, Jae Gardella, Kellen Vo Vu et autres
PET using established and emerging molecularly targeted radiotracers has become integral to the evaluation and management of brain tumors, providing biologic information that complements conventional MRI to improve tumor characterization, treatment planning, and response assessment across a broad spectrum of neurooncologic diseases. …
us
(code pays fourni par la source)
2026
article
OpenAlex
Valentina Marulanda-Corzo, Sophia Coraci, Preeti Kakkar, Tobechukwu Joseph Okobi et autres
Abstract Radiopharmaceutical therapy, a form of targeted radionuclide therapy, has emerged as a rapidly advancing area in prostate cancer management, with significant developments in 2025. The field, which began to transform from pain palliation to cancer‐directed end points with the α‐emitting agent …
us
(code pays fourni par la source)
2026
conference-abstract
OpenAlex
Sophia Coraci, Valentina Marulanda Corzo, Christopher E. Barbieri, Brian D. Robinson et autres
267 Background: Genomic Classifiers (GC) are increasingly used at the initial staging of prostate cancer to refine prognosis and guide treatment planning. The Decipher genomic classifier is a validated prognostic tool in prostate cancer, that predicts the risk of metastasis and prostate …
us
(code pays fourni par la source)